The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

BOTOX 50 Allergan Units Powder for solution for injection

AbbVie LimitedPA1824/017/002

Main Information

Trade NameBOTOX 50 Allergan Units Powder for solution for injection
Active SubstancesBotulinum Toxin Type A
Dosage FormPowder for solution for injection
Licence HolderAbbVie Limited
Licence NumberPA1824/017/002

Group Information

ATC CodeM03AX Other muscle relaxants, peripherally acting agents
M03AX01 botulinum toxin


License statusAuthorised
Licence Issued18/01/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back